AEGFX
Price
$61.15
Change
-$0.70 (-1.13%)
Updated
Jul 24 closing price
Net Assets
140.66B
WCMIX
Price
$27.68
Change
-$0.13 (-0.47%)
Updated
Jul 24 closing price
Net Assets
21.68B
Interact to see
Advertisement

AEGFX vs WCMIX

AEGFX vs WCMIX Comparison Chart in %
View a ticker or compare two or three
VS
AEGFX vs. WCMIX commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEGFX is a Hold and WCMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEGFX has more cash in the bank: 141B vs. WCMIX (21.7B). AEGFX pays higher dividends than WCMIX: AEGFX (2.53) vs WCMIX (0.71). AEGFX was incepted earlier than WCMIX: AEGFX (25 years) vs WCMIX (15 years). WCMIX (1.05) is less costly to investors than AEGFX (0.86). AEGFX is a more actively managed with annual turnover of: 50.00 vs. WCMIX (23.00). AEGFX has a lower initial minimum investment than WCMIX: AEGFX (250) vs WCMIX (100000). WCMIX annual gain was more profitable for investors over the last year : 4.58 vs. AEGFX (2.28). WCMIX return over 5 years is better than : 0.12 vs. AEGFX (-6.65).
AEGFXWCMIXAEGFX / WCMIX
Total Expense Ratio0.861.0582%
Annual Report Gross Expense Ratio0.861.0582%
Fund Existence25 years15 years-
Gain YTD1.64611.77714%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets141B21.7B650%
Annual Yield % from dividends2.530.71356%
Returns for 1 year2.284.5850%
Returns for 3 years16.1324.2966%
Returns for 5 years-6.650.12-5,754%
Returns for 10 years43.70117.4837%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQNTX25.600.11
+0.43%
MFS Equity Income R3
FCADX60.49N/A
N/A
Fidelity Advisor International Discv C
IGFAX5.39N/A
N/A
VY® Morgan Stanley Global Franchise A
OBSIX39.15N/A
N/A
Oberweis Small-Cap Opportunities Instl
BRSTX16.69-0.01
-0.06%
MFS Blended Research Small Cap Eq R3